Learning Objectives 1. Discuss the increased risks of first-trimester pregnancy loss and congenital malformations associated with mycophenolate 2. Provide or facilitate effective patient education about risks of mycophenolate exposure during pregnancy and the need for contraception 3. Check pregnancy status in all female patients of reproductive potential 4. Evaluate potential alternative treatment options for patients who are considering pregnancy 5. Report any pregnancies that occur during treatment with mycophenolate or within 6 weeks following discontinuation of treatment
- Provider:Partners for Advancing Clinical Education (PACE)
- Activity Link: https://nexusmedx.com
- Start Date: 2024-11-01 05:00:00
- End Date: 2024-11-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours - MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Mycophenolate REMS Group - Amount: 220000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Jointly Provided
- Registration: Open to all
- Specialty: Adolescent Medicine, Adult Congenital Heart Disease, Advanced Heart Failure and Transplant Cardiology, Cardiovascular Disease, Clinical Cardiac Electrophysiology, Critical Care Medicine, Endocrinology, Diabetes, and Metabolism, Gastroenterology, Hematology, Hospital Medicine, Infectious Disease, Internal Medicine, Interventional Cardiology, Medical Oncology, Nephrology, Neurocritical Care, Pulmonary Disease, Rheumatology, Sleep Medicine, Sports Medicine, Transplant Hepatology
Subscribe
Login
0 Comments
Oldest